Athira | SCHEDULE 13G/A:其他
Athira | SCHEDULE 13G/A:其他
Athira | 4:持股变动声明-高管 CHURCH KEVIN
Athira | 4:持股变动声明-高管 San Martin Javier
Athira | 4:持股变动声明-高管 Litton Mark James
Athira | 4:持股变动声明-高管 Worthington Mark
Athira | 4:持股变动声明-高管 Renninger Robert
Athira | 144:拟议出售证券
Athira | 144:拟议出售证券
Athira | 144:拟议出售证券
Athira | 144:拟议出售证券
Athira | SC 13G/A:超过5%持股股东披露文件(修正)-Baker Bros. Advisors LP(0.0%),Baker Bros. Advisors (GP) LLC(0.0%)等
Athira | 10-Q:2024财年三季报
Athira | 8-K:Athira Pharma公布2024年第三季度财务业绩以及管道和业务更新
Athira | SC 13G:超过5%持股股东披露文件-Braden M Leonard(6.5%),BML Investment Partners, L.P.(5.8%)
Athira | SC 13D/A:超过5%持股股东披露文件(修正)-Joseph Edelman(14.2%),Perceptive Advisors LLC(14.1%)等
Athira | EFFECT:其他
Athira | UPLOAD:其他
Athira | CORRESP:信函
Athira | S-3:特定交易注册声明